American academic medical center Mayo Clinic plans to trial generative AI technology on Google Cloud. The nonprofit first announced a 10-year strategic partnership with Google back in 2019. Mayo ...

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

NEW YORK & LAS VEGAS, April 09, 2025--UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models.

A new myTomorrows survey of physicians in the United States highlights the need for smarter, AI-driven tools to overcome ...

Google on Thursday announced the second cohort to take part in its AI Academy: American Infrastructure, which seeks to ...

Google DeepMind's drug discovery arm, Isomorphic Labs, is almost ready to begin human trials of its AI-designed drugs.In an interview with Fortune, Colin Murdoch, President of Isomorphic Labs and ...